2021
DOI: 10.1590/1678-9199-jvatitd-2020-0154
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Inflammation is closely related to renal diseases. This is particularly true for renal diseases caused by infections as in viral diseases. In this review, we highlight the inflammatory mechanisms that underlie kidney dysfunction in SARS-CoV-2, human immunodeficiency (HIV), hepatitis C (HCV), and hepatitis B (HBV) infections. The pathophysiology of renal involvement in COVID-19 is complex, but kidney damage is frequent, and the prognosis is worse when it happens. Virus-like particles were demonstrated mostly in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 77 publications
0
2
0
Order By: Relevance
“…The pathway of "Hepatitis B" has been enriched in the KEGG pathway analysis. The impaired liver function, although poorly understood, is an important clinically significant outcome after COVID-19 infection (da Mata et al, 2021;Yu et al, 2021). COVID-19 can also trigger hepatitis B reactivation, but no direct pathophysiological overlap between both diseases has been reported to date (Aldhaleei et al, 2020;.…”
Section: Viral Infection Pathwaysmentioning
confidence: 99%
“…The pathway of "Hepatitis B" has been enriched in the KEGG pathway analysis. The impaired liver function, although poorly understood, is an important clinically significant outcome after COVID-19 infection (da Mata et al, 2021;Yu et al, 2021). COVID-19 can also trigger hepatitis B reactivation, but no direct pathophysiological overlap between both diseases has been reported to date (Aldhaleei et al, 2020;.…”
Section: Viral Infection Pathwaysmentioning
confidence: 99%
“…Importantly, for HCV and SARS-CoV-2, the degree and nature of their interactions and the underlying mechanisms remain largely unexplored, although the potential for disease modulating effects of HCV infection on COVID-19 outcomes, including long COVID symptoms, is highlighted by evidence discussed in recent reviews ( Devi et al, 2021 ; da Mata et al, 2021 ). For example, one study suggests that among patients with HCV and hepatocellular carcinoma, those with undetectable HCV infection may be at a lower risk of fatality than those with active HCV infection, when diagnosed with SARS-CoV-2 infection ( Guler-Margaritis et al, 2021 ).…”
mentioning
confidence: 99%